Effect of Fluticasone 250 μg/salmeterol 50 μg and Montelukast on Exhaled Nitric Oxide in Asthmatic Patients
BACKGROUND: Monitoring noninvasive biomarkers of inflammation is an important adjunct in asthma therapy.
Saved in:
Main Authors: | Arthur F Gelb, Colleen Flynn Taylor, Chris M Shinar, Carlos A Gutierrez, Noe Zamel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2008/415391 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
by: Kenneth R Chapman, et al.
Published: (1999-01-01) -
Flunisolide Decreases Exhaled Nitric Oxide and Nitrotyrosine Levels in Asthmatic Children
by: A. Bodini, et al.
Published: (2006-01-01) -
The Effects of 2 μG and 4 μG Doses of Dexmedetomidine in Combination with Intrathecal Hyperbaric Bupivacaine on Spinal Anesthesia and its Postoperative Analgesic Characteristics
by: Abdulkadir Yektaş, et al.
Published: (2014-01-01) -
Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Hilla Mills, et al.
Published: (2022-01-01) -
Onset of Bronchodilation and Finger Tremor Induced by Salmeterol and Salbutamol in Asthmatic Patients
by: Jan Lötvall, et al.
Published: (1998-01-01)